Heparin protects basic and acidic FGF from inactivation
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The ability of heparin or that of hexuronyl hexosaminoglygan sulfate (HHS‐4) to protect basic or acidic fibroblast growth factor (FGF) from acid or heat inactivation has been analyzed. Both freshly prepared basic and acidic FGF stimulate the growth of baby hamster kidney (BHK‐21) cells exposed to medium supplemented with transferrin and insulin. Freshly prepared basic FGF was 10 fold more potent than acidic FGF. The addition of heparin to the medium decreased the potency of basic FGF while it potentiated that of acidic FGF. Upon storage of FGF at −80°C, a decline in potency of both basic and acidic FGF was observed. Heparin, when added to the medium, potentiated their activities, which became similar to that of freshly prepared basic FGF. In order to test whether heparin could protect basic or acidic FGF from inactivation, both mitogens were exposed to acid conditions (1% trifluoroacetic acid, pH 1.08, 2 h) or heat (65°C, 5 min) which inactivate basic or acidic FGF. When exposed to such treatment in the presence of heparin or HHS‐4, basic and acidic FGF retained their potency. The effect of heparin and HHS‐4 on the bioactivity of basic and acidic FGF is truly of a protective nature, since they had no effect when added after inactivation of the mitogens. Potentiation of the bioactivity of the protected mitogens or of the inactivated one could only be observed when cells were exposed to high heparin or HHS‐4 concentrations. This indicates that heparin and HHS‐4, in addition to protecting FGF from inactivation, also acts at another locus, as yet unidentified.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Binding of FGF-2 to heparan sulfate also imparts stability to the growth factor.”
From Interactions between extracellular matrix and growth factors in wound healing (2009) · cites this paper as [40]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Epidermal Growth Factor and a New Derivative
Savage, C. R., & Cohen, S. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)44568-7 · Cited by 1,208
Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor
Shing, Y., Folkman, J., Sullivan, R., Butterfield, C., Murray, J., & Klagsbrun, M. (1984) · Science · doi:10.1126/science.6199844 · Cited by 933
Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation
Thornton, S. C., Mueller, S. N., & Levine, E. M. (1983) · Science · doi:10.1126/science.6635659 · Cited by 793
Esch, F., Baird, A., Ling, N., Ueno, N., Hill, F., Denoroy, L., Klepper, R., Gospodarowicz, D., Böhlen, P., & Guillemin, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.19.6507 · Cited by 693
Self-citationCultured endothelial cells produce heparinlike inhibitor of smooth muscle cell growth
Castellot, J., Addonizio, M., Rosenberg, R., & Karnovsky, M. (1981) · The Journal of Cell Biology · doi:10.1083/jcb.90.2.372 · Cited by 679
Gospodarowicz, D., Cheng, J., Lui, G. M., Baird, A., & Böhlent, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6963 · Cited by 613
Self-citationPurification of a fibroblast growth factor from bovine pituitary.
Gospodarowicz, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41631-1 · Cited by 591
Self-citationPurification of the fibroblast growth factor activity from bovine brain.
Gospodarowicz, D., Bialecki, H., & Greenburg, G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34863-9 · Cited by 492
Self-citation
Research works printed but not linked: 1
- Gospodarowicz D., 1986, Methods in Enzymology
Cited by
Items 301–400 of 902
Williams, G., Chang, S., Comaratta, M. R., & Simoni, G. J. (1996) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/bf00184858 · Cited by 72
“However, heparin can also promote the stability of growth factors protecting them f rom heat or enzymatic degradation [9] and small heparin fragments can activate bFGF by binding the growth factor to its receptor [18].”
BackgroundLi, X., Tang, J., Bao, L., Chen, L., & Hong, F. F. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.08.120 · Cited by 72
Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia
Alioto, R. J., Rosier, R. N., Burton, R. I., & Puzas, J. E. (1994) · The Journal Of Hand Surgery · doi:10.1016/0363-5023(94)90059-0 · Cited by 72
Sannes, P. L., Burch, K. K., & Khosla, J. (1992) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/7.2.230 · Cited by 73
Heparin Mimicking Polymer Promotes Myogenic Differentiation of Muscle Progenitor Cells
Sangaj, N. S., Kyriakakis, P., Yang, D., Chang, C., Arya, G., & Varghese, S. (2010) · Biomacromolecules · doi:10.1021/bm101041f · Cited by 71
Li, L.-Y., Safran, M., Aviezer, D., Boehlen, P., Seddon, A. P., & Yayon, A. (1994) · Biochemistry · doi:10.1021/bi00202a020 · Cited by 71
Brito, A., Abul‐Haija, Y. M., da Costa, D. S., Novoa-Carballal, R., Reis, R. L., Ulijn, R. V., Pires, R. A., & Pashkuleva, I. (2018) · Chemical Science · doi:10.1039/c8sc04361b · Cited by 70
Bashkin, P., Razin, E., Eldor, A., & Vlodavsky, I. (1990) · Blood · doi:10.1182/blood.v75.11.2204.2204 · Cited by 69
Chen, L., He, Z., Chen, B., Yang, M., Zhao, Y., Sun, W., Xiao, Z., Zhang, J., & Dai, J. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3827-9 · Cited by 69
“The action mechanism between heparin and GFs is related partly to shape recognition, but primarily to electrostatic attractions between Nand O-sulfated residues of heparin and the lysine and arginine residues of the GFs [28, 29].”
BackgroundUdomluck, N., Lee, H., Hong, S., Lee, S., & Park, H. (2020) · Applied Surface Science · doi:10.1016/j.apsusc.2020.146311 · Cited by 69
Stem cell therapy in the heart: Biomaterials as a key route
Hashemzadeh, M. R., Yazdi, M. E. T., Amiri, M. S., & Mousavi, S. H. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101504 · Cited by 70
Autocrine regulation of cell growth and transformation by basic fibroblast growth factor
Yayon, A., & Klagsbrun, M. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00046360 · Cited by 69
“It is possible that external autocrine stimulation by bFGF released from cells over-expressing bFGF can confer growth advantage in vitro but may prove to be inefficient in vivo since soluble, non-matrix bound bFGF is very labile and rapidly inactivated [83-85].”
BackgroundKlagsbrun, M., & Folkman, J. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74781-6_19 · Cited by 69
Gautschi-Sova, P., Jiang, Z. P., Fràter‐Schröder, M., & Boehlen, P. (1987) · Biochemistry · doi:10.1021/bi00392a039 · Cited by 69
Wang, Z., Sun, B., Zhang, M., Ou, L., Che, Y., Zhang, J., & Kong, D. (2012) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911512469707 · Cited by 68
Mitchell, C. A., McGeachie, J. K., & Grounds, M. D. (1996) · Growth Factors · doi:10.3109/08977199609034565 · Cited by 68
Plichta, J. K., & Radek, K. A. (2012) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e318240540a · Cited by 67
Besner, G. E., Whelton, D., Crissman-Combs, M. A., Steffen, C. L., Kim, G. Y., & Brigstock, D. R. (1992) · Growth Factors · doi:10.3109/08977199209046411 · Cited by 67
Arthritis and mast cell activation
Mican, J. M., & Metcalfe, D. D. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80240-4 · Cited by 67
Weber, S., Krüger‐Krasagakes, S., Grabbe, J., Zuberbier, T., & Czarnetzki, B. M. (1995) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1995.tb04366.x · Cited by 67
Kampa, R. J., & Connell, D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02432.x · Cited by 66
Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin
Zakrzewska, M., Więdłocha, A., Szlachcic, A., Krowarsch, D., Otlewski, J., & Olsnes, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001289 · Cited by 66
Miralem, T., Steinberg, R., Price, D. R. G., & Avraham, H. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204753 · Cited by 66
“In some cell types, the presence of heparin-like molecules is essential for the binding of b-FGF to its receptors (Rapraeger et al., 1991; Yayon et al., 1991), thereby protecting b-FGF from heat and acidic inactivation (Gospodarowicz and Cheng, 1986).”
BackgroundRichard, C., Liuzzo, J. P., & Moscatelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24188 · Cited by 67
Modulation of Wound Repair by Members of the Fibroblast Growth Factor Family
Abraham, J. A., & Klagsbrun, M. (1988) · Springer eBooks · doi:10.1007/978-1-4899-0185-9_6 · Cited by 66
Jiang, T., Khan, Y., Nair, L. S., Abdel‐Fattah, W. I., & Laurencin, C. T. (2009) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32615 · Cited by 65
Drug releasing systems in cardiovascular tissue engineering
Spadaccio, C., Chello, M., Trombetta, M., Rainer, A., Toyoda, Y., & Genovese, J. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00532.x · Cited by 65
“Another approach Drug/growth factor Biomaterial Dexamethasone Poly(D,L-lactic-co-glycolic acid) (PLGA) [89] PLGA microspheres/poly(vinyl alcohol) hydrogel composite [40] VEGF Poly(lactide-co-glycolide) (PLG) [109] Fibrin [222] Collagen [223] Gelatine [224] Alginate [114] PDGF-BB Poly(D,L-lactic-co-glycolic acid) (PLGA…”
BackgroundKim, S. H., & Kiick, K. (2007) · Peptides · doi:10.1016/j.peptides.2007.08.010 · Cited by 59
“In particular, heparin has been shown to protect growth factors from inactivation [22,45], increase their affinity to receptors [49], improve the loading efficiency of growth factor into delivery vehicles [34], and sustain the release of growth factors over extended periods of time [33,34].”
BackgroundbFGF enhances the development of the collateral circulation after acute arterial occlusion
Chleboun, J. O., Martins, R. N., Mitchell, C. A., & Chirilă, T. V. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91654-9 · Cited by 65
Ontogeny of basic fibroblast growth factor binding sites in mouse ocular tissues
Fayein, N. A., Courtois, Y., & Jeanny, J. C. (1990) · Experimental Cell Research · doi:10.1016/0014-4827(90)90280-n · Cited by 65
Biofunctionalized PEDOT-coated microfibers for the treatment of spinal cord injury
Alves-Sampaio, A., García‐Rama, C., & Collazos-Castro, J. E. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.02.037 · Cited by 65
Extracellular Matrix-Bound Growth Factors, Enzymes, and Plasma Proteins
Vlodavsky, I., Bar‐Shavit, R., Korner, G., & FUKS, Z. Y. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-593165-6.50022-x · Cited by 64
Koledova, Z. S., Sumbal, J., Rabata, A., Bourdonnaye, G. D. L., Chaloupková, R., Hrdličková, B., Damborský, J., & Štěpánková, V. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00331 · Cited by 63
“Several studies suggested that the main role of heparin/HS in FGFR signaling is to protect FGF against proteolytic degradation (Gospodarowicz and Cheng, 1986; Zakrzewska et al., 2009) and to stabilize the FGF2-FGFR complex (Fannon and Nugent, 1996; Lundin et al.”
BackgroundThe Origin and Fate of Muscle Satellite Cells
Aziz, A., Sebastian, S., & Dilworth, F. J. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9352-0 · Cited by 63
“For example, FGFs have heparin binding sites that allow sequestration by the extracellular matrix [108], circulating IGF’s remain bound to inactivating IGF binding proteins [109], while TGF-β is found in its latent form by association with a larger protein complex [110].”
BackgroundMori (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8692 · Cited by 63
Effect of polyanions on the unfolding of acidic fibroblast growth factor
Burke, C. J., Volkin, D. B., Mach, H., & Middaugh, C. R. (1993) · Biochemistry · doi:10.1021/bi00076a015 · Cited by 63
EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS
Kelly, C. M., Tyers, P., Borg, M. G. T., Svendsen, C. N., Dunnett, S. B., & Rosser, A. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.08.020 · Cited by 62
Barker, K. A., Hampe, A., Stoeckle, M. Y., & Hanafusa, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3528-3533.1993 · Cited by 62
“It has been suggested that attachment to the ECM may act as storage for a protein, in which it is protected from thermal denaturation or extremes of pH (16).”
BackgroundKilkenny, D. M., & Rocheleau, J. V. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0241 · Cited by 62
Basic Fibroblast Growth Factor Synthesis by Human Peritoneal Mesothelial Cells
Cronauer, M. V., Stadlmann, S., Klocker, H., Abendstein, B. J., Eder, I. E., Rogatsch, H., Zeimet, A. G., Marth, C., & Offner, F. A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65516-2 · Cited by 62
Mach, H., & Middaugh, C. R. (1995) · Biochemistry · doi:10.1021/bi00031a013 · Cited by 62
Sauer-Eriksson, A. E., Matthews, B. W., & Cousens, L. S. (1993) · Protein Science · doi:10.1002/pro.5560020810 · Cited by 62
Bârzu, T., Lormeau, J. C., Petitou, M., Michelson, S., & Choay, J. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400320 · Cited by 62
Mercier, F., & Douet, V. (2014) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2014.03.005 · Cited by 61
“In addition to act as co-receptors for growth factors such as those of the FGF family (Yayon et al., 1991), HSPG can function as a reservoir protecting growth factors from inactivation and proteolysis (Gospodarowics and Cheng, 1986; Moscatelli, 1988).”
Effect of Gelatin on Heparin Regulation of Cytokine Release from Hyaluronan-Based Hydrogels
Peattie, R. A., Pike, D. B., Yu, B., Cai, S., Shu, X. Z., Prestwich, G. D., Firpo, M. A., & Fisher, R. J. (2008) · Drug Delivery · doi:10.1080/10717540802035442 · Cited by 61
Coltrini, D., Rusnati, M., Zoppetti, G., Oreste, P., Isacchi, A., Caccia, P., Bergonzoni, L., & Presta, M. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17895.x · Cited by 62
Chinen, N., Tanihara, M., Nakagawa, M., Shinozaki, K., Yamamoto, E., Mizushima, Y., & Suzuki, Y. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10061 · Cited by 61
Hurley, M. M., Kessler, M., Gronowicz, G., & Raisz, L. G. (1992) · Endocrinology · doi:10.1210/endo.130.5.1374012 · Cited by 64
Radek, K. A., Taylor, K. R., & Gallo, R. L. (2009) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00449.x · Cited by 54
“It is possible that this discrepancy between cell/matrix bound GAG and soluble GAG may elicit diverse effects, particularly involving the FGFs.”
BackgroundInfluentialBrain-metastatic melanoma: a neurotrophic perspective
Marchetti, D., Denkins, Y. M., Reiland, J., Greiter‐Wilke, A., Galjour, J., Murry, B. P., Blust, J., & Roy, M. (2003) · Pathology & Oncology Research · doi:10.1007/bf03033729 · Cited by 59
Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation
Nissen, N. N., Shankar, R., Gamelli, R. L., Singh, A. K., & DiPietro, L. A. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380637 · Cited by 59
Poppas, D. P., Massicotte, J. M., Stewart, R. B., Roberts, A. B., Atala, A., Retik, A. B., & Freeman, M. R. (1996) · Lasers in Surgery and Medicine · doi:10.1002/(sici)1096-9101(1996)19:3<360::aid-lsm13>3.0.co;2-8 · Cited by 59
Feng, C., Zhang, C., Shao, X., Liu, Q., Qian, Y. J., Feng, L., Chen, J. Y., Zha, Y., Zhang, Q., & Jiang, X. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.008 · Cited by 58
A Glycopolymer Chaperone for Fibroblast Growth Factor-2
Guan, R., Sun, X., Hou, S., Wu, P., & Chaikof, E. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034138t · Cited by 58
Tavornvipas, S., Hirayama, F., Takeda, S., Arima, H., & Uekama, K. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20715 · Cited by 58
A Novel Technique to Propagate Primary Human Preadipocytes without Loss of Differentiation Capacity
Skurk, T., Ecklebe, S., & Hauner, H. (2007) · Obesity · doi:10.1038/oby.2007.349 · Cited by 58
“It was originally suggested to use a combination of a growth factor together with heparin in a molar ratio of 1:1 to enhance the growth factor effect of aFGF (24).”
BackgroundMurata, M., Hara, K., & Saku, T. (1997) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1997.tb01228.x · Cited by 58
FGF-2 but not FGF-1 binds fibrin and supports prolonged endothelial cell growth
Sahni, A., Altland, O. D., & Francis, C. W. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00250.x · Cited by 58
Immobilised heparin accelerates the healing of human wounds in vivo
Kratz, G., Back, M., Arnander, C., & Larm, O. (1998) · Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery · doi:10.1080/02844319850158462 · Cited by 58
Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion.
Carroll, S. M., White, F. C., Roth, D. M., & Bloor, C. M. (1993) · Circulation · doi:10.1161/01.cir.88.1.198 · Cited by 58
Bone resorption induced by a metastatic human melanoma cell line
Hiraga, T., Nakajima, T., & Ozawa, H. (1995) · Bone · doi:10.1016/8756-3282(94)00048-4 · Cited by 58
Effects of pH and Polyanions on the Thermal Stability of Fibroblast Growth Factor 20
Fan, H., Vitharana, S. N., Chen, T., O'Keefe, D. O., & Middaugh, C. R. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060097h · Cited by 57
Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection
Kang, I., Chang, M. Y., Wight, T. N., & Frevert, C. W. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417751880 · Cited by 57
Watanabe, T., Seno, M., Sasada, R., & Igarashi, K. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-6-869 · Cited by 57
Mechanisms of FGF gradient formation during embryogenesis
Balasubramanian, R., & Zhang, X. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.10.004 · Cited by 56
Tumova, S., Hatch, B. A., Law, D. J., & Bame, K. J. (1999) · Biochemical Journal · doi:10.1042/bj3370471 · Cited by 57
Liu, G., Wu, R., Yang, B., Shi, Y., Deng, C., Atala, A., Mou, S. S., Criswell, T. L., & Zhang, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.005 · Cited by 56
“Interactions occur in part by shape recognition, but mostly through the electrostatic attractions between N- and O-sulfated residues of heparin and the lysine/arginine residues of growth factors [47, 48].”
BackgroundEnoxaparin in Experimental Stroke: Neuroprotection and Therapeutic Window of Opportunity
Mary, V., Wahl, F., Uzan, A., & Stutzmann, J. M. (2001) · Stroke · doi:10.1161/01.str.32.4.993 · Cited by 56
The Stability of bFGF Against Thermal Denaturation
Vemuri, S., Beylin, I., Sluzky, V., Stratton, P., Eberlein, G. A., & Wang, Y. J. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03831.x · Cited by 56
Analysis of Putative Heparin-binding Domains of Fibroblast Growth Factor-1
Wong, P., Hampton, B., Szylobryt, E., Gallagher, A. M., Jaye, M., & Burgess, W. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25805 · Cited by 52
Regulation of cell function by extracellular matrix
Schnaper, H. W., & Kleinman, H. K. (1993) · Pediatric Nephrology · doi:10.1007/bf00861587 · Cited by 58
Basic fibroblast growth factor secreted by an animal tumor is detectable in urine.
Soutter, A. D., Nguyen, M. T. N., Watanabe, H., & Folkman, J. (1993) · PubMed · Cited by 56
Serum‐free mouse embryo cells: Growth responses in vitro
Loo, D. T., Rawson, C., Helmrich, A., & Barnes, D. W. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390306 · Cited by 56
Feige, J., Bradley, J. D., Fryburg, K., Farris, J., Cousens, L. C., Barr, P. J., & Baird, A. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.6.3105 · Cited by 56
“The solution was cooled, and basic FGF was immunoprecipitated with antibodies to basic FGF(1-24) conjugated to Al~gel-10 beads (Bio-Rnd Laboratories, Cambridge, MA).”
BackgroundMethodHeparin-functionalized chitosan scaffolds for bone tissue engineering
Gümüşderelíoğlu, M., & Aday, S. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.12.007 · Cited by 55
Paluck, S. J., Nguyen, T. H. T., Lee, J. P., & Maynard, H. D. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b01182 · Cited by 55
Ogura, K., Nagata, K., Hatanaka, H., Habuchi, H., Kimata, K., Tate, S., Ravera, M. W., Jaye, M., Schlessinger, J., & Inagaki, F. (1999) · Journal of Biomolecular NMR · doi:10.1023/a:1008330622467 · Cited by 55
Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig
Soubrane, G., Cohen, S. Y., Delayre, T., Tassin, J., Hartmann, M.-P., Coscas, G. J., Courtois, Y., & Jeanny, J.-C. (1994) · Current Eye Research · doi:10.3109/02713689408995776 · Cited by 50
Quyyumi, A. A., Diodati, J. G., Lakatos, E., Bonow, R. O., & Epstein, S. E. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90169-2 · Cited by 55
Buğra, K., Oliver, L., Jacquemin, E., Laurent, M., Courtois, Y., & Hicks, D. (1993) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1993.tb00228.x · Cited by 55
“enzymatic degradation (Gospodarowicz and Cheng, 1986; S o w e r and Rifkin, 1989), it may favour an immune response directed against a folded configuration.”
BackgroundPeschel, D., Zhang, K., Aggarwal, N., Brendler, E., Fischer, S., & Groth, T. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.12.032 · Cited by 54
Mohan, H., Friese, A., Albrecht, S., Krumbholz, M., Elliott, C. L., Arthur, A., Menon, R., Farina, C., Junker, A., Stadelmann, C., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0168-9 · Cited by 49
“The interaction of FGF1 with its receptors is stabilize d and stimulation efficacy is increased by binding to heparan sulfate [57-60].”
BackgroundKarey, K. P., Marquardt, H., & Sirbasku, D. (1989) · Blood · doi:10.1182/blood.v74.3.1084.1084 · Cited by 54
Fuller, K., Gallagher, A. C., & Chambers, T. J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81382-8 · Cited by 54
Brown, A., Robinson, C., Gallagher, J. T., & Blundell, T. L. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.02.051 · Cited by 54
“Heparin is sufficient to promote the mitogenic action of FGFs on cells deficient in HS (14) and also protects FGFs from proteolysis and thermal denaturation (15,16).”
BackgroundHeparin based polyurethanes: A state-of-the-art review
Zia, F., Zia, K. M., Zuber, M., Tabasum, S., & Rehman, S. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.12.004 · Cited by 54
Biological molecule-impregnated polyester: an in vivo angiogenesis study
Fournier, N., & Doillon, C. J. (1996) · Biomaterials · doi:10.1016/0142-9612(96)87645-9 · Cited by 53
Giuliani, R., Bastaki, M., Coltrini, D., & Presta, M. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.15.2597 · Cited by 53
Myler, H. A., & West, J. L. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003182 · Cited by 53
Mesenchymal Cell Growth Factors
Graves, D. T., & Cochran, D. L. (1990) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411900010010301 · Cited by 53
Effect of polyanions on the refolding of human acidic fibroblast growth factor.
Dabora, J. M., Sanyal, G., & Middaugh, C. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54331-3 · Cited by 53
Kraemer, R. T., Pomerantz, K. B., Joseph‐Silverstein, J., & Hajjar, D. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53060-x · Cited by 53
Yan, X., Yokote, H., Jing, X., Yao, L., Sawada, T., Zhang, Y., Liang, S., & Sakaguchi, K. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00853.x · Cited by 52
“The requirement of heparin might be due to the nature of FGF23; theirs is mouse normal FGF23 while ours is human FGF23 with an ADHR-type mutation, since the proteolysis-protective and potentiating effects of heparin on FGF are well known ( Gospodarowicz & Cheng 1986; Rosengart et al. 1988; Damon et al. 1989).”
BackgroundPiltonen, M., Bespalov, M. M., Ervasti, D., Matilainen, T., Sidorova, Y. A., Rauvala, H., Saarma, M., & Männistö, P. T. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.07.002 · Cited by 52
“HSPGs also protect ligands from cleavage and thus prolong their action (Rickard et al., 2003; Gospodarowicz and Cheng, 1986).”
BackgroundMi, F., Shyu, S., Peng, C., Wu, Y., Sung, H., Wang, P., & Huang, C. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30298 · Cited by 52
Perspectives of Gene Therapy in Stem Cell Tissue Engineering
GOESSLER, U. R., Riedel, K., Hörmann, K., & Riedel, F. (2006) · Cells Tissues Organs · doi:10.1159/000096508 · Cited by 52
“Many strategies – including polymers, pumps and heparin – have been tested in attempts to achieve consistent growth factor levels at the injured site [Gospodarowicz and Cheng, 1986; Mitchell et al., 1996].”
BackgroundZhang, J., Postovit, L.-M. M., Wang, D., Gardiner, R. B., Harris, R. A., Abdul, M., & Thomas, A. (2009) · Nanoscale Research Letters · doi:10.1007/s11671-009-9395-6 · Cited by 52
Tiefenbacher, C., & Chilian, W. M. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00029-1 · Cited by 52
Layer-by-Layer Incorporation of Growth Factors in Decellularized Aortic Heart Valve Leaflets
De Cock, L. J., De Koker, S., De Vos, F., Vervaet, C., Remon, J.-P., & De Geest, B. G. (2010) · Biomacromolecules · doi:10.1021/bm9014649 · Cited by 49
Fannon, M. W., Forsten‐Williams, K., Dowd, C. J., Freedman, D. A., Folkman, J., & Nugent, M. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0935fje · Cited by 52
Metadata
- Authors
- Gospodarowicz, D., & Cheng, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Gospodarowicz, D.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 1986-09
- Volume
- 128
- Issue
- 3
- Pages
- 475-484
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1972855766
- Cited by
- 853
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 13 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 18 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 22
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Cellular Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 20197)
- National Eye Institute (EY02186)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- heparin, basic fibroblast growth factor, acidic fibroblast growth factor, acid inactivation, thermal inactivation
- MeSH terms
- Animals, Cell Division, Cell Line, Fibroblast Growth Factors, Fibroblasts, Glycosaminoglycans, Cricetinae, Hot Temperature, Heparin, Hydrogen-Ion Concentration, Insulin, Kidney, Mesocricetus, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.